Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats
Nitroalkene derivatives of nitro-oleic acid (OA-NO2) are endogenous lipid products with novel signaling properties, particularly the activation of PPARs. The goal of this proposal was to examine the therapeutic potential of this OA-NO2 in treatment of obesity and obesity-related conditions in obese...
Main Authors: | Haiping Wang, Haiying Liu, Zhanjun Jia, Guangju Guan, Tianxin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2010/601562 |
Similar Items
-
Nitro-Oleic Acid Attenuates OGD/R-Triggered Apoptosis in Renal Tubular Cells via Inhibition of Bax Mitochondrial Translocation in a PPAR-γ-Dependent Manner
by: Huibin Nie, et al.
Published: (2015-02-01) -
AZ 242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats
by: Bengt Ljung, et al.
Published: (2002-11-01) -
Leucine and protein metabolism in obese Zucker rats.
by: Pengxiang She, et al.
Published: (2013-01-01) -
Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis
by: Nicholas K.H. Khoo, et al.
Published: (2019-04-01) -
The PPARα/γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat
by: Kristina Wallenius, et al.
Published: (2013-01-01)